Related Experiment Videos
Summary
The IBM 2997 processor yielded higher granulocyte counts than the Fenwal CS-3000 during leukapheresis. Platelet yields were comparable between the two blood cell processing systems.
Area of Science:
- Transfusion Medicine
- Hematology
- Biomedical Engineering
Background:
- Apheresis procedures are critical for obtaining specific blood components.
- Evaluating the efficiency of different blood cell processing systems is essential for optimizing component collection.
Purpose of the Study:
- To compare the performance of the IBM 2997 and Fenwal CS-3000 blood processors.
- To assess granulocyte and platelet yields and efficiencies during leukapheresis and plateletpheresis.
Main Methods:
- Two blood processors, IBM 2997 and Fenwal CS-3000, were evaluated under standardized conditions.
- Leukapheresis and plateletpheresis procedures were conducted, with data collected on cell yields and processing efficiencies.
- The Fenwal CS-3000 was tested at two different whole blood flow rates (50 ml/min and 60 ml/min).
Main Results:
- The IBM 2997 demonstrated significantly higher granulocyte yields (19.4 x 10^9) compared to the Fenwal CS-3000 (13.3-14.2 x 10^9) during leukapheresis.
- Platelet yields were comparable between the IBM 2997 (3.62 x 10^11) and Fenwal CS-3000 (3.15-4.3 x 10^11) during plateletpheresis.
- The IBM 2997 showed higher granulocyte collection efficiency (42.5%) than the Fenwal CS-3000 (30.5-39.2%).
Conclusions:
- The IBM 2997 processor is more effective for granulocyte collection than the Fenwal CS-3000.
- Both systems provide comparable platelet yields, suggesting suitability for platelet concentrate production.
- Flow rate adjustments on the Fenwal CS-3000 had a moderate impact on granulocyte and platelet yields and efficiencies.